SUGEAK Trademark

Trademark Overview

On Friday, July 9, 2010, a trademark application was filed for SUGEAK with the United States Patent and Trademark Office. The USPTO has given the SUGEAK trademark a serial number of 85081132. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 16, 2018. This trademark is owned by sanofi-aventis. The SUGEAK trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of cancer
sugeak

General Information

Serial Number85081132
Word MarkSUGEAK
Filing DateFriday, July 9, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 16, 2018
Registration Number4008476
Registration DateTuesday, August 9, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2011

Trademark Statements

Certificate of Correction for RegistrationIn the statement, Column 1, line 1, "sanofi-aventis" and corporation should be deleted, and "Sanofi" and "societe anonyme" should be inserted.
Goods and Servicespharmaceutical preparations for the prevention and treatment of cancer
Translation of Words in MarkThe wording "SUGEAK" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressParis 75013
FR
Party NameSANOFI
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis 75013
FR
Party Namesanofi-aventis
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75013
FR

Trademark Events

Event DateEvent Description
Friday, March 16, 2018CANCELLED SEC. 8 (6-YR)
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 7, 2014CORRECTION UNDER SECTION 7 ¿ PROCESSED
Wednesday, March 5, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 7, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 7, 2012TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 22, 2011AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Thursday, August 18, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 17, 2011TEAS SECTION 7 REQUEST RECEIVED
Tuesday, August 9, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, June 1, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 24, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2011PUBLISHED FOR OPPOSITION
Monday, April 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 18, 2011ASSIGNED TO LIE
Monday, April 4, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 29, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 29, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 29, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 29, 2011NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 29, 2011INQUIRY TO SUSPENSION E-MAILED
Tuesday, March 29, 2011SUSPENSION INQUIRY WRITTEN
Wednesday, September 29, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 29, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, September 29, 2010SUSPENSION LETTER WRITTEN
Monday, September 27, 2010ASSIGNED TO EXAMINER
Tuesday, July 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 13, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

sugeak cancer treatment prevention preparations pharmaceutical